NHE-1 Peptide Reference: GTX85047-PEP NHE-1 peptide is used for blocking the activity of NHE-1 antibody (catalog number GTX8547). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Rat EGF Reference: GFR5-250 Epidermal Growth Factor (EGF) is a growth factor that stimulates the proliferation, differentiation, and survival of epithelial and epidermal cells. EGF contains three intramolecular disulfide bonds and binds in high affinity to the epidermal growth factor receptor (EGFR). EGF is overexpressed in multiple tumor cell lines and promotes resistance to chemotherapy and radiation treatments.
Orai1 Peptide Reference: GTX85048-PEP ORAI1 peptide is used for blocking the activity of ADAP antibody (catalog number GTX8548). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Rat EGF Reference: GFR5-1000 Epidermal Growth Factor (EGF) is a growth factor that stimulates the proliferation, differentiation, and survival of epithelial and epidermal cells. EGF contains three intramolecular disulfide bonds and binds in high affinity to the epidermal growth factor receptor (EGFR). EGF is overexpressed in multiple tumor cell lines and promotes resistance to chemotherapy and radiation treatments.
Carabin Peptide Reference: GTX85049-PEP Carabin peptide is used for blocking the activity of Carabin antibody (catalog number GTX8549). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human EG-VEGF Reference: GFH7-5 Endocrine Gland-derived Vascular Endothelial Growth Factor (EG-VEGF) is an angiogenic growth factor that is expressed in the ovaries, testis, adrenal, and placental tissues. EG-VEGF has mitogenic, chemoattractive, and antiapoptotic functional roles. EG-VEGF signaling is mediated through binding the G protein-coupled receptors prokineticin receptor 1 (PKR1) and prokineticin receptor 2 (PKR2). Polycystic ovaries display strong EG-VEGF expression that is associated with increased angiogenesis and cyst formation, which could lead to the formation of polycystic ovary syndrome and infertility.
Carabin Peptide Reference: GTX85050-PEP Carabin peptide is used for blocking the activity of Carabin antibody (catalog number GTX855). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human EG-VEGF Reference: GFH7-20 Endocrine Gland-derived Vascular Endothelial Growth Factor (EG-VEGF) is an angiogenic growth factor that is expressed in the ovaries, testis, adrenal, and placental tissues. EG-VEGF has mitogenic, chemoattractive, and antiapoptotic functional roles. EG-VEGF signaling is mediated through binding the G protein-coupled receptors prokineticin receptor 1 (PKR1) and prokineticin receptor 2 (PKR2). Polycystic ovaries display strong EG-VEGF expression that is associated with increased angiogenesis and cyst formation, which could lead to the formation of polycystic ovary syndrome and infertility.
HUWE1 Peptide Reference: GTX85051-PEP HUWE1 peptide is used for blocking the activity of HUWE1 antibody (catalog number GTX8551). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human EG-VEGF Reference: GFH7-100 Endocrine Gland-derived Vascular Endothelial Growth Factor (EG-VEGF) is an angiogenic growth factor that is expressed in the ovaries, testis, adrenal, and placental tissues. EG-VEGF has mitogenic, chemoattractive, and antiapoptotic functional roles. EG-VEGF signaling is mediated through binding the G protein-coupled receptors prokineticin receptor 1 (PKR1) and prokineticin receptor 2 (PKR2). Polycystic ovaries display strong EG-VEGF expression that is associated with increased angiogenesis and cyst formation, which could lead to the formation of polycystic ovary syndrome and infertility.
CRLF2 Peptide Reference: GTX85052-PEP TSLP receptor peptide is used for blocking the activity of TSLP receptor antibody (catalog number GTX8552). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human EG-VEGF Reference: GFH7-1000 Endocrine Gland-derived Vascular Endothelial Growth Factor (EG-VEGF) is an angiogenic growth factor that is expressed in the ovaries, testis, adrenal, and placental tissues. EG-VEGF has mitogenic, chemoattractive, and antiapoptotic functional roles. EG-VEGF signaling is mediated through binding the G protein-coupled receptors prokineticin receptor 1 (PKR1) and prokineticin receptor 2 (PKR2). Polycystic ovaries display strong EG-VEGF expression that is associated with increased angiogenesis and cyst formation, which could lead to the formation of polycystic ovary syndrome and infertility.